Compare AIRE & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AIRE | BNGO |
|---|---|---|
| Founded | 2021 | 2003 |
| Country | United States | United States |
| Employees | N/A | 97 |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5M | 12.9M |
| IPO Year | 2023 | 2018 |
| Metric | AIRE | BNGO |
|---|---|---|
| Price | $2.07 | $1.14 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $1.30 | ★ $7.00 |
| AVG Volume (30 Days) | 69.0K | ★ 127.4K |
| Earning Date | 04-28-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 60.34 | ★ 94.50 |
| EPS | ★ N/A | N/A |
| Revenue | $4,518,498.00 | ★ $12,000,735.00 |
| Revenue This Year | $129.06 | $14.99 |
| Revenue Next Year | $83.72 | $34.73 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 376.42 | 26.26 |
| 52 Week Low | $0.14 | $1.06 |
| 52 Week High | $3.98 | $5.50 |
| Indicator | AIRE | BNGO |
|---|---|---|
| Relative Strength Index (RSI) | 48.96 | 41.95 |
| Support Level | $1.89 | $1.13 |
| Resistance Level | $2.40 | $1.18 |
| Average True Range (ATR) | 0.19 | 0.04 |
| MACD | -0.05 | -0.00 |
| Stochastic Oscillator | 38.27 | 16.23 |
ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform. It develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for the analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability. The company's reportable segments are Homebuying Services and the Technology Services segment.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.